Epazz MSHealth Completing a Software Project Worth
Post# of 1228
Mar 25, 2015
OTC Disclosure & News Service
-
Epazz MSHealth Completing a Software Project Worth Over $78,000 for a Midwest State Government
CHICAGO, IL--(Marketwired - March 25, 2015) - Epazz Inc. (OTCQB: EPAZ), a leading provider of cloud-based business software solutions announced today that its wholly-owned subsidiary MSHealth is completing a contract worth over $78,000 for a Midwest state government. MSHealth software was replaced in 2014. The pervious software was over 20 years old. The replacement software is using the latest technologies allowing for the company to attract new projects.
"Our business model is to take legacy software and convert it into Cloud business applications. MSHealth is another example of the changing trend towards Cloud business applications. We believe MSHealth will have a great year upgrading existing customers and acquiring new customers into the new software," said Shaun Passley, Ph.D. CEO of Epazz, Inc.
About Epazz Inc.
Epazz Inc. is a leading cloud-based software company that specializes in providing customized cloud applications to the corporate world, higher education institutions, and the public. Epazz BoxesOS™v3.0 is the complete web-based business software package for small to midsize businesses, Fortune 500 enterprises, government agencies, and higher education institutions. Epazz's other products are MSHealth™, a mental health software and AutoHire™, an applicant tracking system.
SAFE HARBOR
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:
Certain statements contained in this press release are "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements generally can be identified by the use of forward-looking statements such as "may," "expect," "intend," "estimate," "anticipate," "believe," or "continue" (or the negative thereof) or similar terminology. Such forward-looking statements are subject to risk, uncertainties, and other factors that could cause actual results to differ materially from future results or implied by such forward-looking statements. Investors are cautioned that any forward-looking statements are not guarantees of future performance and that actual results may differ materially from those contemplated by such forward-looking statements. Epazz assumes no obligation and does not intend to update these forward-looking statements and takes no obligation to update or correct information prepared by third parties that are not paid by Epazz. Investors are encouraged to review Epazz's public filings on SEC.gov, including its unaudited and audited financial statements, its Registration Statement, Form 10-Ks, and Form 10-Qs, which contain general business information about the Company's operations, results of operations, and risks associated with the Company and its operations. Epazz could be a good penny stock pick, but please visit our website and do your research.
For more information, please contact:
Epazz, Inc.
Investor Relations
investors@epazz.net
(312) 955-8161
www.epazz.com
Copyright © 2015 Marketwired. All Rights Reserved
The above news release has been provided by the above company via the OTC Disclosure and News Service. Issuers of news releases and not OTC Markets Group Inc. are solely responsible for the accuracy of such news releases.
Epazz, Inc. (EPAZ) Stock Research Links
1️⃣I do not provide personal investment advice and I am not a qualified licensed investment advisor. I am an amateur investor.
2️⃣All information found here, including any ideas, opinions, views, predictions, forecasts, commentaries, suggestions, or stock picks, expressed or implied herein, are for informational, entertainment or educational purposes only and should not be construed as personal investment advice. While the information provided is believed to be accurate, it may include errors or inaccuracies.
3️⃣I will not and cannot be held liable for any actions you take as a result of anything you read here.
4️⃣Conduct your own due diligence, or consult a licensed financial advisor or broker before making any and all investment decisions. Any investments, trades, speculations, or decisions made on the basis of any information found on this site, expressed or implied herein, are committed at your own risk, financial or otherwise.